PEPFAR News and Research

RSS

Botswana launches infant HIV testing program

Botswana in a ceremony in Francistown -- attended by Mark Dybul, who serves as the U.S. global AIDS coordinator and administers the President's Emergency Plan for AIDS Relief -- launched a program to test six-month-old infants for HIV, according a U.S. embassy statement released on Wednesday, SAPA/SABC News reports.

30 Oct 2006

Zambia's use of resources to fight HIV/AIDS model for other countries

Zambia has demonstrated how to use donor funding effectively for HIV prevention and treatment programs at the community and ministerial levels, and the country could serve as a model for other nations, Mark Dybul -- who serves as the U.S. global AIDS coordinator and administers the President's Emergency Plan for AIDS Relief -- said on Friday during a visit to the country, Zambia's Daily Mail reports.

23 Oct 2006

Fight against HIV/AIDS in Africa should focus more on blood safety

A renewed focus on unsafe blood transfusions and used syringes is needed to combat the spread of HIV in sub-Saharan Africa, Ambassador Mark Dybul -- who serves as the U.S. global AIDS coordinator and administers the President's Emergency Plan for AIDS Relief -- said on Wednesday during a visit to Zambia, Reuters reports.

19 Oct 2006

Boston Globe examines influence religious conservatives might have on USAID

The Boston Globe as part of a series examined the amount of influence religious conservatives might have on grants administered by USAID, including HIV prevention grants for the President's Emergency Plan for AIDS Relief.

16 Oct 2006

FDA approves Atripla three-drug combination tablet for treatment of HIV-1

FDA approves Atripla Tablets, a fixed-dose combination of three widely-used antiretroviral drugs.

12 Jul 2006

FDA gives tentative approval for generic pediatric AIDS drug

The Food and Drug Administration (FDA) today announced the tentative approval of the generic version of Abacavir Sulfate Oral Solution.

27 Jun 2006

FDA gives tentative approval to new generic AIDS drug

The Food and Drug Administration (FDA) today announced the tentative approval of generic abacavir sulfate tablets manufactured by Aurobindo Pharma LTD. of Hyderabad, India.

18 May 2006

Johns Hopkins launches program to improve public health education in Africa

The Johns Hopkins Bloomberg School of Public Health will lead a five-year initiative to strengthen the capacity of public health schools in East Africa.

5 Apr 2006

EU advice for Africans - ignore Bush when it comes to AIDS

In what is seen as a major split with the United States over the AIDS pandemic, Europe, led by the UK, is tacitly urging African governments not to listen to the abstinence-focused agenda of the Bush administration.

2 Dec 2005

Ranbaxy receives tentative FDA approval to manufacture and market Zidovudine tablets

India's Ranbaxy Laboratories has announced that it has received tentative approval from the U.S. Food and Drug Administration (USFDA) to manufacture and market Zidovudine Tablets USP, 300 mg.

15 Jul 2005

Tentative approval for Lamivudine tablets

The U.S. Food and Drug Administration (FDA) has announced the tentative approval of Lamivudine Tablets manufactured by Aurobindo Pharma LTD. Hyderabad, India.

16 Jun 2005

Global Health Service needed to fight AIDS

A report by the non-partisan Institute of Medicine is calling for the creation of a U.S. Global Health Service comprised of doctors, nurses and other health care workers to help combat HIV/AIDS in the world's hardest hit countries.

20 Apr 2005

Call for a United States Global Health Service

The federal government should create and fund an umbrella organization called the United States Global Health Service (GHS) to mobilize the nation's best health care professionals and other experts to help combat HIV/AIDS in hard-hit African, Caribbean, and Southeast Asian countries, says a new report from the Institute of Medicine of the National Academies.

19 Apr 2005

Ranbaxy files additional Anti-Retroviral (ARV) agents with the World Health Organization

Ranbaxy Laboratories Limited (RLL) announced today that the Company has made two additional filings of its Anti-Retroviral (ARV) agents with the World Health Organization (WHO) for its approval, taking the total number of Ranbaxy ARV filings submitted with the WHO to five.

23 Mar 2005

Ranbaxy files anti-retrovirals (ARVs) to the U.S. FDA

Ranbaxy Laboratories Limited (Ranbaxy) announced today that the Company has so far made three filings of its Anti-Retrovirals (ARVs) to the U.S. FDA for its approval under the expedited review process of the President's Emergency Plan for AIDS Relief (PEPFAR).

10 Jan 2005

Safety of AIDS drug to prevent mother-to-child transmission of HIV questioned

In light of several recent drug industry scandals roiling the nation's public health and raising serious questions about the US bodies that license and regulate the industry -- and startling new revelations today concerning National Institutes of Health (NIH) officials and the safety of a brand name AIDS drug used to prevent mother-to-child transmission of the HIV

14 Dec 2004

FDA Vioxx fiasco raises questions about AIDS drug approvals for developing world

AIDS Healthcare Foundation (AHF), today noted that the current "FDA fiasco" involving the agency's initial approval and subsequent recall of Merck's troubled arthritis drug, Vioxx, raises serious questions about the FDA's ongoing parallel role in the approval of generic AIDS drugs for widespread use in Africa and the developing world.

19 Nov 2004